265 related articles for article (PubMed ID: 32373607)
1. Organoid Models of Glioblastoma to Study Brain Tumor Stem Cells.
Azzarelli R
Front Cell Dev Biol; 2020; 8():220. PubMed ID: 32373607
[TBL] [Abstract][Full Text] [Related]
2. A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo.
Hubert CG; Rivera M; Spangler LC; Wu Q; Mack SC; Prager BC; Couce M; McLendon RE; Sloan AE; Rich JN
Cancer Res; 2016 Apr; 76(8):2465-77. PubMed ID: 26896279
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional culture models to study glioblastoma - current trends and future perspectives.
Joseph JV; Blaavand MS; Daubon T; Kruyt FA; Thomsen MK
Curr Opin Pharmacol; 2021 Dec; 61():91-97. PubMed ID: 34656940
[TBL] [Abstract][Full Text] [Related]
4. Utility of the Cerebral Organoid Glioma 'GLICO' Model for Screening Applications.
Weth FR; Peng L; Paterson E; Tan ST; Gray C
Cells; 2022 Dec; 12(1):. PubMed ID: 36611949
[TBL] [Abstract][Full Text] [Related]
5. Enhanced targeting of invasive glioblastoma cells by peptide-functionalized gold nanorods in hydrogel-based 3D cultures.
Gonçalves DPN; Rodriguez RD; Kurth T; Bray LJ; Binner M; Jungnickel C; Gür FN; Poser SW; Schmidt TL; Zahn DRT; Androutsellis-Theotokis A; Schlierf M; Werner C
Acta Biomater; 2017 Aug; 58():12-25. PubMed ID: 28576716
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional organoid culture unveils resistance to clinical therapies in adult and pediatric glioblastoma.
Sundar SJ; Shakya S; Barnett A; Wallace LC; Jeon H; Sloan A; Recinos V; Hubert CG
Transl Oncol; 2022 Jan; 15(1):101251. PubMed ID: 34700192
[TBL] [Abstract][Full Text] [Related]
7. Modeling liver cancer and therapy responsiveness using organoids derived from primary mouse liver tumors.
Cao W; Liu J; Wang L; Li M; Verstegen MMA; Yin Y; Ma B; Chen K; Bolkestein M; Sprengers D; van der Laan LJW; Doukas M; Kwekkeboom J; Smits R; Peppelenbosch MP; Pan Q
Carcinogenesis; 2019 Mar; 40(1):145-154. PubMed ID: 30289434
[TBL] [Abstract][Full Text] [Related]
8. Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.
Logan S; Arzua T; Canfield SG; Seminary ER; Sison SL; Ebert AD; Bai X
Compr Physiol; 2019 Mar; 9(2):565-611. PubMed ID: 30873582
[TBL] [Abstract][Full Text] [Related]
9. The Organoid Era Permits the Development of New Applications to Study Glioblastoma.
Andreatta F; Beccaceci G; Fortuna N; Celotti M; De Felice D; Lorenzoni M; Foletto V; Genovesi S; Rubert J; Alaimo A
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33182346
[TBL] [Abstract][Full Text] [Related]
10. [Progress in prostate cancer study: 3D cell culture enables the ex vivo reproduction of tumor characteristics].
Tostivint V; Racaud-Sultan C; Roumiguié M; Soulié M; Gamé X; Beauval JB
Presse Med; 2017 Oct; 46(10):954-965. PubMed ID: 28967525
[TBL] [Abstract][Full Text] [Related]
11. Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases.
Cosset E; Locatelli M; Marteyn A; Lescuyer P; Dall Antonia F; Mor FM; Preynat-Seauve O; Stoppini L; Tieng V
J Vis Exp; 2019 Jun; (148):. PubMed ID: 31305527
[TBL] [Abstract][Full Text] [Related]
12. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
13. An alginate-based platform for cancer stem cell research.
Qiao SP; Zhao YF; Li CF; Yin YB; Meng QY; Lin FH; Liu Y; Hou XL; Guo K; Chen XB; Tian WM
Acta Biomater; 2016 Jun; 37():83-92. PubMed ID: 27109764
[TBL] [Abstract][Full Text] [Related]
14. The Renin-Angiotensin System in the Tumor Microenvironment of Glioblastoma.
O'Rawe M; Kilmister EJ; Mantamadiotis T; Kaye AH; Tan ST; Wickremesekera AC
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439159
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic heterogeneity of 2D organoid reflects clinical tumor characteristics.
Fujino S; Ito A; Ohue M; Yasui M; Mizushima T; Doki Y; Mori M; Miyoshi N
Biochem Biophys Res Commun; 2019 May; 513(2):332-339. PubMed ID: 30955861
[TBL] [Abstract][Full Text] [Related]
16. Glioblastoma Organoids: Pre-Clinical Applications and Challenges in the Context of Immunotherapy.
Klein E; Hau AC; Oudin A; Golebiewska A; Niclou SP
Front Oncol; 2020; 10():604121. PubMed ID: 33364198
[TBL] [Abstract][Full Text] [Related]
17. Novel therapies hijack the blood-brain barrier to eradicate glioblastoma cancer stem cells.
Vengoji R; Ponnusamy MP; Rachagani S; Mahapatra S; Batra SK; Shonka N; Macha MA
Carcinogenesis; 2019 Mar; 40(1):2-14. PubMed ID: 30475990
[TBL] [Abstract][Full Text] [Related]
18. The Akt/mTOR pathway in cancer stem/progenitor cells is a potential therapeutic target for glioblastoma and neuroblastoma.
Bahmad HF; Mouhieddine TH; Chalhoub RM; Assi S; Araji T; Chamaa F; Itani MM; Nokkari A; Kobeissy F; Daoud G; Abou-Kheir W
Oncotarget; 2018 Sep; 9(71):33549-33561. PubMed ID: 30323898
[TBL] [Abstract][Full Text] [Related]
19. Selective enrichment of CD133
Lv K; Chen Z; Zhang X; Zhang Q; Liu L
Oncol Lett; 2018 Oct; 16(4):4567-4576. PubMed ID: 30197675
[TBL] [Abstract][Full Text] [Related]
20. Sarcoma Spheroids and Organoids-Promising Tools in the Era of Personalized Medicine.
Colella G; Fazioli F; Gallo M; De Chiara A; Apice G; Ruosi C; Cimmino A; de Nigris F
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29466296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
